Skip to main content

Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.

Bihm DJ, Ettinger A, Buytaert-Hoefen KA, Hendrix BK, Maldonado-Codina G, Rock G, Giclas PC, Goodrich RP

Publication: Vox Sang (2010) • Vol 98 • Page 108-15PMID: 19719460View on PubMed

Purpose

The purpose of this paper was to determine the effects of collection method, pathogen reduction with riboflavin and ultraviolet (UV) light irradiation, and storage at -30 degrees C on the levels of markers of 10 coagulation, 6 anticoagulant/inhibitor, 4 complement and 6 immunoglobulin (Ig) proteins in fresh frozen plasma (FFP).

Conclusion

Collection method (apheresis versus whole-blood derived plasma) did not affect the levels of any analyte. After storage for up to 104 weeks, 57-94% of the levels of coagulation proteins found in untreated (control) FFP were found in FFP treated with riboflavin and UV light exposure. After storage for up to 69 weeks, 90% or more of anticoagulant and inhibitor protein levels found in control FFP were retained in riboflavin/UV-treated FFP. After storage for 69 weeks, significant decreases in C3a, C1 inhibitor antigen, CH50, total IgG, IgG1, IgG4, and IgM were observed in riboflavin/UV-treated FFP compared to levels in control FFP.

Studies (1)

Purpose

The purpose of this study was to determine the effects of collection method, pathogen reduction with riboflavin addition and UV irradiation, and storage at -30 degrees C on the levels of markers of 10 coagulation, 6 anticoagulant/inhibitor, 4 complement and 6 Ig proteins in FFP from blood donors. Plasma obtained by apheresis with citrate dextrose or from whole blood with citrate phosphate dextrose was held for 8 h at room temperature, aliquots were removed and left at room temperature (control), and the remaining plasma was combined with riboflavin (vitamin B) solution and exposed to UV light. Following light treatment, both the treated plasma and the control plasma were flash frozen and then stored at -30 degrees C.

Summary of Findings

Analysis of plasma collected by apheresis rather than whole-blood derived plasma did not affect the levels of any analyte in FFP. After storage for 36 weeks, 67% of the level of factor VII in control FFP was found in riboflavin/UV-treated FFP, and 64% of the level of factor V in control FFP was measured in riboflavin/UV-treated FFP. After storage for 69 weeks, riboflavin/UV-treated FFP retained 66-94% of the coagulation protein levels found in control FFP. After 87 weeks of storage, riboflavin/UV-treated FFP retained 63% of the factor VIII activity and 57% of the factor XI activity measured in control FFP, while 74-86% of all other coagulation protein levels measured in control FFP were retained in riboflavin/UV-treated FFP. After 104 weeks of frozen storage, 57-90% of the levels of coagulation proteins measured in control FFP were retained in riboflavin/UV-treated FFP, with the greatest loss measured in factor VII. After 69 weeks of storage, 90% or more of the anticoagulant and inhibitor protein levels measured in control FFP were retained in riboflavin/UV-treated FFP. After storage for 69 weeks, significant decreases in C3a, C1 inhibitor antigen, CH50, total IgG, IgG1, IgG4, and IgM were observed in riboflavin/UV-treated FFP compared to levels in control FFP.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
  • Platforms

    ProteinELISA
    ProteinClinical chemistry/auto analyzer
    GlycoproteinClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionMethod of fluid acquisition
    Apheresis
    Venipuncture
    Biospecimen AcquisitionPre-preservation condition
    No riboflavin/UV light exposure
    Treated with riboflavin and UV light exposure
    Biospecimen Aliquots and ComponentsBlood processing method
    No riboflavin/UV light exposure
    Treated with riboflavin and UV light exposure
    StorageStorage duration
    104 weeks
    36 weeks
    69 weeks
    87 weeks